I agree that this site is using cookies. You can find further informations here.
X
Augereau, Adeline
30  results:
Search for persons X
?
1

Naked mole rat TRF1 safeguards glycolytic capacity and telo..:

Augereau, Adeline ; Mariotti, Marco ; Pousse, Mélanie...
Science Advances.  7 (2021)  8 - p. , 2021
Link: https://doi.org/10.1126/..
 
?
2

INK4 locus of the tumor-resistant rodent, the naked mole ra..:

Tian, Xiao ; Azpurua, Jorge ; Ke, Zhonghe...
Proceedings of the National Academy of Sciences of the United States of America.  112 (2015)  4 - p. 1053-1058 , 2015
Link: https://www.jstor.org/st..
 
?
3

INK4locus of the tumor-resistant rodent, the naked mole rat..:

Tian, Xiao ; Azpurua, Jorge ; Ke, Zhonghe...
Proceedings of the National Academy of Sciences.  112 (2014)  4 - p. 1053-1058 , 2014
Link: https://doi.org/10.1073/..
 
?
4

TRF2 inhibits a cell-extrinsic pathway through which natura..:

Biroccio, Annamaria ; Cherfils-Vicini, Julien ; Augereau, Adeline...
Nature Cell Biology.  15 (2013)  7 - p. 818-828 , 2013
Link: https://doi.org/10.1038/..
 
?
5

Naked mole rat TRF1 safeguards glycolytic capacity and telo..:

Augereau, Adeline ; Mariotti, Marco ; Pousse, Mélanie...
info:eu-repo/semantics/altIdentifier/doi/10.1126/sciadv.abe0174.  , 2021
Link: https://hal.science/hal-..
 
?
6

Naked mole rat TRF1 safeguards glycolytic capacity and telo..:

Augereau, Adeline ; Mariotti, Marco, 1984- ; Pousse, Mélanie...
Reproducció del document publicat a: https://doi.org/10.1126/sciadv.abe0174.  , 2021
Link: http://hdl.handle.net/24..
 
?
7

Naked mole rat TRF1 safeguards glycolytic capacity and telo..:

Augereau, Adeline ; Mariotti, Marco ; Pousse, Mélanie...
uri/info:doi/10.1126/sciadv.abe0174.  , 2021
Link: http://hdl.handle.net/20..
 
?
8

INK4 locus of the tumor-resistant rodent, the naked mole ra..:

Tian, Xiao ; Azpurua, Jorge ; Ke, Zhonghe...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313802/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
9

The human TTAGGG repeat factors 1 and 2 bind to a subset of..:

Simonet, Thomas ; Zaragosi, Laure-Emmanuelle ; Philippe, Claude...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193489.  , 2011
Link: http://www.ncbi.nlm.nih...
 
?
10

Treatment and outcomes in patients with central nervous sys..:

Pasquier, David ; Darlix, Amélie ; Louvel, Guillaume...
European Journal of Cancer.  125 (2020)  - p. 22-30 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Treatment and outcomes in patients with central nervous sys..:

Pasquier, David ; Darlix, Amélie ; Louvel, Guillaume...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2019.11.001.  , 2020
Link: https://hal.science/hal-..
 
?
12

Treatment and outcomes in patients with central nervous sys..:

Pasquier, David ; Darlix, Amélie ; Louvel, Guillaume...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2019.11.001.  , 2020
Link: https://hal.science/hal-..
 
?
13

Treatment and outcomes in patients with central nervous sys..:

Pasquier, David ; Darlix, Amélie ; Louvel, Guillaume...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2019.11.001.  , 2020
Link: https://hal.science/hal-..
 
?
14

Treatment and outcomes in patients with central nervous sys..:

Pasquier, David ; Darlix, Amélie ; Louvel, Guillaume...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2019.11.001.  , 2020
Link: https://hal.science/hal-..
 
?
15

Treatment and outcomes in patients with central nervous sys..:

Pasquier, David ; Darlix, Amélie ; Louvel, Guillaume...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2019.11.001.  , 2020
Link: https://hal.science/hal-..
 
1-15